Source Intelligence Evolves With C-Map: Delivering Next-Generation SaaS Platform for Compliance & Sustainability
The platform delivers faster risk identification, seamless data access, and streamlined workflows
SAN DIEGO, CA / ACCESSWIRE / November 4, 2024 / Source Intelligence has evolved with C-Map, a next-generation software as a service (SaaS) platform that empowers enterprises to manage compliance and sustainability with greater efficiency. Designed to address the increasing complexities of today's regulatory landscape, this powerful platform combines robust automation capabilities, Artificial Intelligence (AI), and in-house regulatory expertise to help companies tackle increasing compliance demands and mitigate emerging risks.
Source Intelligence's logo and tagline - "Trust Your Source"
With regulations evolving faster than ever, compliance teams often struggle with limited resources. Collecting supplier data, responding to documentation requests, and keeping up with shifting requirements create considerable challenges. C-Map reduces manual effort, streamlines workflows, and equips businesses with tools to mitigate risk. These efficiencies translate into tangible outcomes, including:
Rapid risk identification: AI capabilities improve data quality and deliver insights into key risk areas faster. This offers companies better visibility and a stronger return on investment.
Enhanced risk mitigation through precise data collection: Expert-designed templates and assessments help standardize data collection. This allows teams to make informed decisions and address potential risks before they escalate.
Seamless data access with integrated compliance tools: A world-class database integrates with ERP, PLM, and warehousing systems. These integrations enable seamless data exchange, automate compliance checks, and offer real-time visibility into supply chain activities.
Increased efficiency through streamlined workflows: Automated workflows ease internal workloads, enabling businesses to manage compliance and sustainability without relying on consulting or manual labor.
Faster customer request fulfillment: Automated report and declaration generation reduces manual work. This helps companies respond to customer requests quickly and meet demand effectively.
Together, these outcomes empower businesses to reduce risk, enhance efficiency, and maintain control over compliance in a dynamic regulatory environment.
"C-Map represents a significant step forward for Source Intelligence," said Mike Flynn, Chief Product Officer of Source Intelligence. "We recognized that the only way to help businesses tackle increasingly complex regulations was to deliver a platform that offers scalability, flexibility, and automation. Our software is trusted by some of the world's largest and most sophisticated companies to manage compliance at the highest levels, proving its reliability and impact."
With enhanced visibility and control over compliance tasks, businesses across industries - including electronics, medical devices, and industrial manufacturing - can confidently navigate evolving regulations. C-Map offers the flexibility to be self-managed or paired with managed services for additional support. Interested organizations are invited to schedule a demo and experience the platform firsthand.
About Source Intelligence
Source Intelligence simplifies compliance, sustainability, and ESG management through scalable SaaS solutions and managed services, configurable to meet the unique needs of any enterprise. For more information, please visit www.sourceintelligence.com.
Contact Information
Amanda Lindberg
Director of Marketing
amanda.lindberg@sourceintel.com
SOURCE: Source Intelligence
View the original press release on newswire.com.
Source Intelligence
Subscribe to releases from ACCESS Newswire
Subscribe to all the latest releases from ACCESS Newswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from ACCESS Newswire
OBI-902 Has Been Granted by US FDA for Orphan Drug Designation for the Treatment of Cholangiocarcinoma17.11.2025 13:00:00 CET | Press release
OBI-902 is the first ADC utilizing OBI's proprietary GlycOBI® glycan-based ADC enabling technology for evaluation of safety and efficacy in patients with Cancer. TAIPEI, TW / ACCESS Newswire / November 17, 2025 / OBI Pharma, a clinical-stage oncology company (4174.TWO) received notification from the US FDA stating that the request for Orphan Drug Designation of OBI-902 TROP2 ADC for the treatment of Cholangiocarcinoma has been granted. OBI-902 is the first OBI-developed ADC that incorporates our proprietary site-specific glycan-conjugated ADC enabling technology. Cholangiocarcinoma is a rare and lethal malignancy with fewer than 50,000 patients in the United States and a 5-year survival rate ranging from 2% and 23% depending on disease stage, histological subtype, and localization 1 . At present, there are no FDA approved ADC therapies for cholangiocarcinoma. To encourage the industry to develop new treatment options for rare diseases, the US FDA grants Orphan Drug Designation to exper
Camino Completes C$5.6 Million Investment with Strategic Investors17.11.2025 12:00:00 CET | Press release
VANCOUVER, BC / ACCESS Newswire / November 17, 2025 / Camino Minerals Corporation (TSXV:COR)(OTC:CAMZF) ("Camino" or the "Company") is pleased to announce the closing of its -brokered private placement (the "Financing") of common shares in the capital of the Company (the "Shares") previously announced in its news release dated November 12, 2025. Under the Financing, the Company issued an aggregate of 15,554,666 Shares at an issue price of $0.36 per Share, for aggregate gross proceeds of C$5,599,680. Participants in the Financing included two new key shareholders, Elemental Royalties (formerly EMX Royalty Corp.) and Continental General Insurance Company, as well as certain insiders of Camino. The gross proceeds of the Financing will be applied towards corporate working capital, legal expenses, engineering studies, project development, and general administrative expenses. The Shares issued pursuant to the Financing are subject to a statutory hold period expiring on March 15, 2026, in acc
GA-ASI Completes Full-Scale Fatigue Test on MQ-9B17.11.2025 03:10:00 CET | Press release
MQ-9B's Third Lifetime Test Completes the FSF Testing Process With a Total of 120,000 Hours DUBAI, UAE / ACCESS Newswire / November 16, 2025 / On October 31, 2025, General Atomics Aeronautical Systems, Inc. (GA-ASI) completed its "third lifetime" of full-scale fatigue (FSF) testing for the MQ-9B Remotely Piloted Aircraft (RPA). Completion of FSF testing for the third and final lifetime includes a total of 120,000 operating hours (40,000+ flight hours per aircraft life) for the RPA and is a key milestone in validating the design of the airframe. The testing verifies the airframe structural integrity in support of certification to the NATO STANAG 4671 standard. The aim of the testing is to identify any potential structural deficiencies ahead of fleet usage and assist in developing inspection and maintenance schedules for the airframe. Test results will be used as documentation for certification and will form the basis for in-service inspections of structural components. "The completion o
GA-ASI and Saab Will Demonstrate AEW&C on MQ-9B in 202617.11.2025 03:05:00 CET | Press release
Two Aerospace Leaders Are Bringing Airborne Early Warning and Control to UAS DUBAI, UAE / ACCESS Newswire / November 16, 2025 / Following their announcement to bring Airborne Early Warning and Control (AEW&C) capability to the world's leading Remotely Piloted Aircraft (RPA) platform, General Atomics Aeronautical Systems, Inc. (GA-ASI) and Saab will now team up to demonstrate the capability in the summer of 2026. The demo will be conducted at GA-ASI's Desert Horizon flight operations facility in Southern California using a GA-ASI MQ-9B equipped with AEW&C supplied by Saab. In partnership with Saab, a leading company in AEW&C systems, GA-ASI is pairing Saab's AEW sensors with the world's longest-range, highest-endurance RPA, the MQ-9B. At sea or over land, adding AEW capabilities on MQ-9B enables persistent air surveillance and enables AEW in areas of the world where it doesn't currently exist or is unaffordable, such as for navy aircraft carriers at sea. "Adding AEW&C to the MQ-9B bring
Pet-Food Revolution: Two New Global Surveys Reveal Growing Guardian Openness to Sustainable Diets for Dogs and Cats14.11.2025 15:05:00 CET | Press release
LONDON, UK / ACCESS Newswire / November 14, 2025 / Two pioneering studies published in the journal Animals have explored in depth how dog and cat guardians perceive more sustainable pet food options. Led by Jenny L. Mace, Alexander Bauer, Andrew Knight and Billy Nicholles, the research sheds new light on the potential for alternative proteins and plant-based diets in the companion animal sector. Study 1 - Dogs: ‘Consumer Acceptance of Sustainable Dog Diets: A Survey of 2,639 Dog Guardians' In the first study, the team surveyed 2,639 dog guardians worldwide. Around 84% of respondents were currently feeding their dogs either conventional or raw meat-based diets. However, a substantial 43% of this group reported they would nevertheless consider at least one type of more sustainable dog food (such as vegan, vegetarian or cultivated-meat formulations). Among the alternative options, the most acceptable was cultivated meat-based dog food (chosen by 24% of these respondents), compared to vege
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom